The effect of Staphylococcus aureus targeting ROS-dependent mitochondrial damage activating NLRP10 in inducing skin and soft tissue infection Authors: Yan Chen, Jieqiong Wei, Shanshan Wang, Mengna Wang, Xiaobo Ying, Chuanling Zhang Published: 2026 ABSTRACT AbstractMitochondrial dysfunction and reactive oxygen species (ROS) accumulation are central to the pathogenesis of Staphylococcus aureus-induced skin and soft tissue infections (SSTIs). NLRP10 has recently been identified as a key regulator of mitochondrial homeostasis and ROS dynamics. To investigate its regulatory role, we established an in vivo model of methicillin-resistant Staphylococcus aureus (MRSA)-induced SSTIs, which demonstrated significant skin lesions, necrosis, inflammatory infiltration, elevated ROS and LDH levels, decreased NAD+/NADH ratio and ATP content, enhanced apoptosis, and upregulated expression of Cleaved caspase-3, Bax, NLRP10, Cleaved caspase-1, ASC, and phosphorylated NF-κB p65. In vitro, using human primary keratinocytes, NLRP10 knockdown was found to exacerbate MRSA-induced mitochondrial ROS increase, loss of membrane potential, and apoptosis, while attenuating LDH release, ATP depletion, and the secretion of IL-1β/IL-18, as well as reducing the expression of Cleaved caspase-1, ASC, and phosphorylated NF-κB p65. Conversely, NLRP10 overexpression combined with the mitochondrial antioxidant MitoQ alleviated mitochondrial damage and apoptosis but significantly enhanced inflammasome activation and NF-κB pathway signaling. These findings collectively demonstrate that NLRP10 mediates its regulatory effects on Staphylococcus aureus-induced SSTIs through targeting ROS-driven mitochondrial dysfunction.Supplementary InformationThe online version contains supplementary material available at https://doi.org/10.1038/s41598-026-56137-w.Keywords: Skin and soft tissue infections, Staphylococcus aureus, NLRP10, Mitochondrial damage, Reactive oxygen speciesSubject terms: Cell biology, Diseases, Microbiology, Molecular biology, Pathogenesis Introduction Skin and soft tissue infections (SSTIs) are a group of common diseases caused by pathogenic microorganisms, encompassing a wide clinical spectrum from mild furuncles and folliculitis to life-threatening necrotizing fasciitis1. Staphylococcus aureus (S. aureus) is a key pathogen responsible for SSTIs, and its potent pathogenicity poses a significant threat to global public health2. In 2019, S. aureus infections caused approximately 1.105 million deaths across 135 countries3. Of particular concern is the escalating challenge of antimicrobial resistance. For instance, between 2013 and 2018, cases of methicillin-resistant S. aureus (MRSA) infections in pediatric SSTI patients increased nearly eightfold4. Current first-line treatment for SSTIs relies on antibiotics (trimethoprim-sulfamethoxazole, clindamycin, linezolid). However, no single antimicrobial agent has been proven unequivocally superior for SSTI treatment5. Consequently, developing novel therapeutic strategies against S. aureus-induced SSTIs has become a major research focus. S. aureus infection can compromise the skin barrier. For example, in atopic dermatitis patients, it can induce keratinocyte apoptosis and epidermal barrier dysfunction6. Its pathogenicity is closely linked to mitochondrial damage. Studies show that MRSA infection can trigger mitochondrial outer membrane permeabilization, leading to the release of mitochondrial DNA (mtDNA) into the cytosol7. S. aureus-derived extracellular vesicles can also induce mitochondrial dysfunction and apoptosis8. Furthermore, this bacterium can induce necroptosis accompanied by significant mitochondrial damage and reactive oxygen species (ROS) accumulation9. As the cellular powerhouse, normal mitochondrial function is crucial for maintaining homeostasis. However, during infection, mitochondria also become key players in innate immunity. For example, in neutrophils, ROS generated by mitochondrial respiratory chain complex III forms a critical immune complex with NOX2 to clear S. aureus10. However, excessive ROS accumulation leads to mitochondrial damage11. Damaged mitochondria can release signals like ROS to activate the NLRP3 inflammasome, subsequently promoting the caspase-1-dependent maturation of pro-inflammatory cytokines such as interleukin-1β (IL-1β) and interleukin-18 (IL-18), thereby driving inflammation12,13. Within keratinocytes, ROS accumulation drives key mitochondrial perturbations, including collapse of the membrane potential, cytochrome c leakage, and fragmentation of mtDNA14. Thus, mitochondria are not only metabolic regulators but are also deeply involved in the initiation and regulation of inflammatory responses. Inflammasomes are intracellular multiprotein complexes that sense danger signals and initiate inflammatory responses15. NLR family pyrin domain containing 10 (NLRP10, also known as PYPAF5) is a member of the NOD-like receptor family, expressed in various cells and particularly abundant in keratinocytes16. Research indicates NLRP10 is associated with several inflammatory diseases, including atopic dermatitis and psoriasis17–19. Its functions are complex and multifaceted, in Shigella flexneri-infected epithelial cells, NLRP10 exacerbates skin inflammation by destabilizing Abin-1 and activating the NF-κB pathway20. In keratinocyte homeostasis, NLRP10 does not directly affect proliferation but is crucial for differentiation; knocking down NLRP10 leads to differentiation defects and increases susceptibility to apoptosis, while overexpressing NLRP10 confers anti-apoptotic effects by inhibiting caspase-8 recruitment21. Notably, recent research has revealed that mitochondrial damage itself can activate NLRP10, enabling it to form ASC specks and mediate caspase-1-dependent cytokine release independently of mtDNA levels22. Moreover, in other cell types, NLRP10 can respond to advanced glycation end products, activating NF-κB and MAPK pathways and subsequently promoting ROS accumulation23. In summary, within the context of S. aureus infection, NLRP10 may play a dual role. On one hand, it might amplify inflammatory responses to eliminate the pathogen by sensing mitochondrial damage signals. On the other hand, its overactivation could lead to programmed cell death (apoptosis) in keratinocytes, exacerbating tissue damage. This positions NLRP10 as a potential key regulatory target for balancing anti-infective immunity and anti-inflammatory responses. Therefore, this study aims to investigate the role of NLRP10 during S. aureus infection. Through in vitro experiments, we will verify whether S. aureus infection activates NLRP10 via ROS-dependent mitochondrial damage and elucidate how NLRP10 regulates keratinocyte differentiation, inflammatory responses, and cell death (apoptosis) in this process. Concurrently, via in vivo experiments using a mouse skin model of S. aureus infection, we will reveal whether mitochondrial damage activation in keratinocytes influences skin inflammation and cell death by modulating NLRP10 and further dissect the underlying molecular mechanisms. Results Lesion progression, histopathological alterations, and inflammatory cytokine expression in the MRSA-induced mouse skin infection model To characterize the pathological features of MRSA-induced SSTIs, we first established a mouse skin infection model by subcutaneous injection of MRSA into the dorsal skin. Mice receiving sterile saline served as the Control group. On days 2, 3, and 4 post-infection, we monitored lesion progression, and on day 4, we collected skin tissues for histopathological analysis and measurement of pro-inflammatory cytokine levels. As presented in Fig. 1A-B, compared to the Control group, the MRSA-infected model group (Model group) exhibited a significant increase in skin lesion size on days 2, 3, and 4. Histopathological examination (Fig. 1C) revealed that skin tissues from the Control group displayed clear layered structures, regularly arranged collagen fibers, and no evident inflammatory cell infiltration, edema, or necrosis. In contrast, skin tissues from the Model group exhibited massive inflammatory cell infiltration, marked tissue edema and cellular necrosis, along with suppurative changes indicative of bacterial infection. The local inflammatory response was assessed by measuring key pro-inflammatory cytokines in skin tissues. Levels of IL-1β, IL-18, IL-6, and TNF-α were significantly higher in the Model group than in the Control group (Fig. 1D-G). These results confirm the successful establishment of a robust MRSA-induced skin infection model characterized by significant tissue damage and a strong local inflammatory response. Lesion progression, histopathological alterations, and inflammatory cytokine expression in the MRSA-induced mouse skin infection model. (A, B) Representative photographs (A) and quantitative analysis (B) of skin lesions monitored over 4 consecutive days, Control n = 6, Model n = 6. (C) Representative HE‑stained images of skin tissues collected on day 4 post-infection (scale bar, 400 μm: 50×, 100 μm: 200×, 50 μm: 400×). (D–G) Levels of pro‑inflammatory cytokines IL‑1β (D), IL‑18 (E), IL‑6 (F), and TNF‑α (G) in skin tissues collected on day 4 post-infection, Control n = 6, Model n = 6. Data are presented as mean ± SD, **P < 0.01 was considered statistically significant. MRSA infection induces oxidative damage, energy metabolism dysregulation, and apoptosis via activation of NLRP10 and downstream inflammatory signaling in skin tissues We further assessed oxidative damage, energy metabolism and apoptosis in the infected tissues. To evaluate oxidative stress, energy metabolism, and cell death in skin tissues collected on day 4 post-infection, we measured ROS levels, LDH release, the NAD+/NADH ratio, and ATP content, and performed TUNEL staining and Western blotting. The level of ROS was significantly elevated in the skin tissues of the Model group (Fig. 2A). Enzymatic activity assays (Fig. 2B-D) revealed that, compared to the Control group, the Model group exhibited a significant increase in LDH release, alongside a marked decrease in both the ratio of NAD+/NADH and ATP content. TUNEL staining (Fig. 2E-F) indicated a significantly higher percentage of apoptotic cells in the Model group compared to the Control group. Western blot analysis further confirmed (Fig. 2G) that the expression levels of Cleaved caspase-3, Bax, NLRP10, Cleaved caspase-1, ASC, and the ratio of p-NF-κB p65 to total NF-κB p65 were all significantly upregulated in the Model group relative to the Control group (Fig. 2H-N). In summary, MRSA infection not only caused oxidative damage and energy metabolism disruption in skin tissue but also activated apoptosis, NLRP10 expression, and downstream inflammatory signaling pathways, suggesting that NLRP10 may be involved in the infection-induced pathological process. MRSA infection induces oxidative damage, energy metabolism dysregulation, and apoptosis via activation of NLRP10 and downstream inflammatory signaling in skin tissues. All assays were performed on tissue samples collected on day 4 post-infection. (A) Quantitative analysis of reactive oxygen species levels in skin tissues, Control n = 6, Model n = 6. (B–D) Quantitative analysis of lactate dehydrogenase release (B), the ratio of oxidized to reduced nicotinamide adenine dinucleotide (C), and adenosine triphosphate content (D) in skin tissues, Control n = 6, Model n = 6. (E, F) Representative images of TUNEL staining for apoptosis detection in skin tissues (E) (scale bar, 100 μm: 200×, 50 μm: 400×) and quantitative analysis of the percentage of apoptotic cells (F), Control n = 3, Model n = 3. (G–N) Representative Western blot bands (G) and quantitative analysis of relative expression levels of Cleaved caspase-3, Bax, NLRP10, Cleaved caspase-1, ASC, p-NF-κB p65, and NF-κB p65 (H–N) in skin tissues, Control n = 3, Model n = 3. Data are presented as mean ± SD, **P < 0.01 was considered statistically significant. NLRP10 knockdown in human primary keratinocytes aggravates mitochondrial damage but partially alleviates metabolic dysfunction induced by S. aureus infection Having established that MRSA skin infection induces ROS accumulation, NLRP10 upregulation, mitochondrial dysfunction, and inflammatory pathway activation in vivo, we next sought to determine whether S. aureus directly activates NLRP10 via ROS-dependent mitochondrial damage in keratinocytes. To this end, we performed loss-of-function experiments in human primary keratinocytes by transfecting cells with si-NLRP10 to knock down NLRP10 expression, followed by exposure to S. aureus infection (Figure S1). We then assessed mitochondrial function, cellular injury, and apoptosis to determine whether NLRP10 influences S. aureus-induced cellular damage. Compared with uninfected control cells, S. aureus infection (Model group) resulted in significantly increased mitochondrial ROS levels (Fig. 3A-B) and LDH release (Fig. 3C), alongside decreased ATP content (Fig. 3D), reduced mitochondrial membrane potential (Fig. 3E-F), and an elevated apoptosis rate (Fig. 3G-H). Knockdown of NLRP10 (Model + si-NLRP10 group) further exacerbated the S. aureus infection-induced elevation in mitochondrial ROS, decline in membrane potential, and increase in apoptosis, but partially attenuated LDH release and the reduction in ATP content. These findings reveal a dual regulatory role for NLRP10 in keratinocytes: on one hand, it helps maintain mitochondrial function and cell survival; on the other hand, it may influence plasma membrane integrity by regulating the inflammatory response pathway. NLRP10 knockdown in human primary keratinocytes aggravates mitochondrial damage but partially alleviates metabolic dysfunction induced by S. aureus infection. (A, B) In NLRP10-knockdown cells, fluorescence representation and quantitative analysis of mitochondrial reactive oxygen species fluorescence intensity (scale bar, 50 μm: 400×), n = 3. (C) In NLRP10-knockdown cells, measurement of lactate dehydrogenase release, n = 3. (D) In NLRP10-knockdown cells, measurement of adenosine triphosphate content, n = 3. (E, F) In NLRP10-knockdown cells, representative image and quantitative analysis of mitochondrial membrane potential (Aggregates/Monomer ratio), n = 3. (G, H) In NLRP10-knockdown cells, measurement of the apoptosis rate, n = 3. Data are presented as mean ± SD, *P < 0.05, **P < 0.01 was considered statistically significant. NLRP10 overexpression in human primary keratinocytes cooperates with MitoQ to alleviate mitochondrial damage and improve cellular metabolic homeostasis induced by S. aureus infection Compared with the Model group, treatment with the mitochondrial-targeted antioxidant MitoQ alone (Model+MitoQ group) significantly inhibited mitochondrial ROS generation (Fig. 4A-B), reduced LDH release (Fig. 4C), increased ATP content (Fig. 4D) and mitochondrial membrane potential (Fig. 4E), and decreased apoptosis (Fig. 4F). Furthermore, overexpression of NLRP10 combined with the mitochondrial antioxidant MitoQ (Model+MitoQ + oe-NLRP10 group) markedly suppressed the MRSA-induced increase in mitochondrial ROS, further increased LDH release, enhanced ATP content, alleviated the loss of membrane potential (Fig. 4G), and significantly diminished apoptosis (Fig. 4H), demonstrating a additive protective effect. This finding reveals a critical functional property of NLRP10: once activated, NLRP10 can function as an autonomous signaling nexus driving downstream inflammatory responses, without requiring sustained ROS signals for maintenance. In other words, ROS-mediated mitochondrial damage serves as the triggering event for NLRP10 activation, but once activated, NLRP10’s effector functions acquire signaling autonomy, operating independently of upstream ROS signals. NLRP10 overexpression in human primary keratinocytes cooperates with MitoQ to alleviate mitochondrial damage and improve cellular metabolic homeostasis induced by S. aureus infection. (A, B) In NLRP10-overexpressing cells, fluorescence representation and quantitative analysis of mitochondrial reactive oxygen species fluorescence intensity (scale bar, 50 μm: 400×), n = 3. (C) In NLRP10-overexpressing cells, measurement of lactate dehydrogenase release, n = 3. (D) In NLRP10-overexpressing cells, measurement of adenosine triphosphate content, n = 3. (E) In NLRP10-overexpressing cells, representative image of mitochondrial membrane potential (Aggregates/Monomer ratio). (F) In NLRP10-overexpressing cells, representative image of the apoptosis rate. (G) In NLRP10-overexpressing cells, quantitative analysis of mitochondrial membrane potential (Aggregates/Monomer ratio), n = 3. (H) In NLRP10-overexpressing cells, quantitative analysis of the apoptosis rate, n = 3. Data are presented as mean ± SD, *P < 0.05, **P < 0.01 was considered statistically significant. NLRP10 mediates IL-1β and IL-18 production in S. aureus-infected human primary keratinocytes To evaluate the regulatory role of NLRP10 on the secretion of inflammasome‑associated cytokines IL‑1β and IL‑18, we examined their levels in NLRP10‑knockdown and NLRP10‑overexpressing cell models. In NLRP10‑knockdown cells, knockdown of NLRP10 alone (si-NLRP10 group) significantly reduced the basal secretion levels of IL‑1β and IL‑18 compared to Control group (Fig. 5A‑B). S. aureus infection (Model group) markedly induced the release of both cytokines. Compared with the infection control (Model + si-NC group), NLRP10 knockdown further significantly suppressed the MRSA‑induced elevation of IL‑1β and IL‑18. In NLRP10‑overexpressing cells, treatment with the mitochondrial antioxidant MitoQ (Model+MitoQ group) significantly inhibited the MRSA infection‑induced release of IL‑1β and IL‑18 (Fig. 5C‑D). Furthermore, overexpression of NLRP10 (Model+MitoQ + oe‑NLRP10 group) significantly increased the levels of IL‑1β and IL‑18 compared to the control group (Model+MitoQ + oe‑NC group), suggesting that NLRP10 plays an important role in regulating inflammasome activation and the maturation of related cytokines This positions NLRP10 as a key regulator of the inflammatory cytokine response to S. aureus infection. NLRP10 mediates IL-1β and IL-18 production in S. aureus-infected human primary keratinocytes. (A, B) Expression levels of IL-1β (A) and IL-18 (B) in NLRP10-knockdown cells, n = 3. (C, D) Expression levels of IL-1β (C) and IL-18 (D) in NLRP10-overexpressing cells, n = 3. Data are presented as mean ± SD, *P < 0.05, **P < 0.01 was considered statistically significant. NLRP10 modulates apoptosis, inflammasome activation, and NF-κB signaling in S. aureus-infected human primary keratinocytes To further elucidate the molecular mechanism of NLRP10 in MRSA infection, we examined the expression of proteins associated with apoptosis, inflammasome activation, and the NF-κB signaling pathway by Western blotting. In NLRP10-knockdown cells (Fig. 6A), MRSA infection (Model group) significantly upregulated the protein levels of Cleaved caspase-3, Bax, NLRP10, Cleaved caspase-1, ASC, p-NF-κB p65, and NF-κB p65 compared to the Control group (Fig. 6B-H). Knockdown of NLRP10 alone (si-NLRP10 group) effectively suppressed the basal expression of NLRP10, Cleaved caspase-1, ASC, and p-NF-κB p65 compared to the si-NC group. Notably, under S. aureus infection, NLRP10 knockdown (Model + si-NLRP10 group) further enhanced the expression of the pro-apoptotic proteins Cleaved caspase-3 and Bax, while significantly reducing the levels of NLRP10, Cleaved caspase-1, p-NF-κB p65, and total NF-κB p65. In NLRP10-overexpressing cells (Fig. 6I), treatment with the mitochondrial antioxidant MitoQ (Model+MitoQ group) markedly inhibited the MRSA-induced increase in NLRP10, Cleaved caspase-1, ASC, and p-NF-κB p65 protein levels (Fig. 6J-N). In contrast, overexpression of NLRP10 (Model+MitoQ + oe-NLRP10 group) reversed this trend, significantly elevating the expression of all detected proteins (NLRP10, Cleaved caspase-1, ASC, p-NF-κB p65, and NF-κB p65). These molecular-level evidence further confirms that NLRP10 plays a central regulatory role in S. aureus infection-induced cell death and inflammatory responses by orchestrating the activation of the NF-κB pathway and inflammasome. NLRP10 modulates apoptosis, inflammasome activation, and NF-κB signaling in S. aureus-infected human primary keratinocytes. (A) Representative Western blot bands of Cleaved caspase-3, Bax, NLRP10, Cleaved caspase-1, ASC, p-NF-κB p65, and NF-κB p65 protein in NLRP10-knockdown cells. (B–H) Quantitative analysis of Cleaved caspase-3, Bax, NLRP10, Cleaved caspase-1, ASC, p-NF-κB p65, and NF-κB p65 protein expression in NLRP10-knockdown cells, n = 3. (I) Representative Western blot bands of NLRP10, Cleaved caspase-1, ASC, p-NF-κB p65, and NF-κB p65 protein in NLRP10-overexpressing cells. (J–N) Quantitative analysis of NLRP10, Cleaved caspase-1, ASC, p-NF-κB p65, and NF-κB p65 protein expression in NLRP10-overexpressing cells, n = 3. Data are presented as mean ± SD, *P < 0.05, **P < 0.01 was considered statistically significant. Discussion This study provides preliminary evidence from in vivo and in vitro experiments suggesting an involvement of NLRP10 in S. aureus-induced SSTIs and its association with mitochondrial damage. The results indicate that S. aureus infection triggers mitochondrial dysfunction and ROS burst, subsequently activating NLRP10. NLRP10 activation exhibits a complex “double-edged sword” characteristic, playing a precise regulatory role between cell death (apoptosis) and inflammatory responses, providing a new perspective for understanding the pathological mechanisms of SSTIs. Traditionally, NLRP3 has been considered the primary inflammasome sensor responsive to mitochondrial damage and ROS24. However, this study and previous research22 indicate that NLRP10 can promote inflammasome activation through mitochondrial damage recognition. Furthermore, NLRP10 regulates keratinocyte survival, differentiation, and barrier integrity, and functions as a scaffold in antimicrobial nodule signaling25. Due to its lack of an LRR domain, NLRP10 functions more like a regulatory factor or adaptor protein18. In this study, MRSA infection led to aggravated inflammation in the animal model, accompanied by increased ROS and LDH levels, decreased NAD+/NADH ratio, and ATP depletion. In vitro, S. aureus infection caused decreased mitochondrial membrane potential and increased apoptosis, whereas scavenging mitochondrial ROS with MitoQ suppressed NLRP10 upregulation and its downstream signaling, confirming that S. aureus activates NLRP10 via a ROS-dependent mitochondrial damage pathway. The observed increase in LDH release concurrent with decreased apoptosis in the NLRP10 overexpression model further supports this notion, as LDH leakage is a hallmark of lytic cell death processes like pyroptosis26, contrasting with the membrane-intact nature of apoptosis. This expands the biological function of NLRP10, establishing it as an important monitor of mitochondrial homeostasis during infection. Its sensing mechanism may involve specific signaling molecules released after mitochondrial outer membrane permeabilization or other unidentified mitochondrial-derived factors, warranting further investigation. The impact of NLRP10 on cell fate appears context-dependent. Under S. aureus infection, NLRP10 knockdown exacerbated mitochondrial damage (manifested as increased ROS and decreased membrane potential) and apoptosis (elevated Cleaved caspase-3 and Bax expression), suggesting that basal levels of NLRP10 may have a protective role in maintaining cell survival and resisting excessive apoptosis. However, NLRP10 knockdown also reduced LDH release and the secretion of IL-1β and IL-18, and inhibited inflammatory response, thereby potentially promoting apoptotic death, a phenomenon consistent with the findings of Zheng et al.16. Conversely, NLRP10 overexpression significantly alleviated mitochondrial damage. Although combined with MitoQ it partially suppressed the overall apoptosis rate, it strongly induced the expression of cleaved Caspase-1 and ASC. This suggests that excessive NLRP10 activation may shift the cell death mode from apoptosis to the more inflammatory pyroptosis. Although this study did not directly detect pyroptosis executioners such as GSDMD, the upregulation of cleaved caspase-1 and the substantial release of IL-1β/IL-18 strongly support that NLRP10 inflammasome activation may lead to pyroptosis. NLRP10 has been shown to assemble into an inflammasome in differentiated keratinocytes, where it plays a role in monitoring mitochondrial integrity in an mtDNA-independent manner. Activation of this pathway can occur via mitochondrial disruption, such as that induced by 3M3-FBS22. Notably, NLRP10 has both anti-inflammatory and inflammasome-dependent functions in innate immunity, NLRP10 can inhibit ASC-mediated NF-κB activation and suppress IL-1β release by hindering caspase-1-mediated IL-1β maturation27,28. Therefore, NLRP10 may function as a “molecular switch” regulating the balance between protective survival signals and destructive inflammatory death signals based on the extent of damage and its own activation state. Mechanistically, this study suggests that NLRP10 may regulate inflammatory responses through two potential pathways. First, NLRP10 knockdown significantly inhibited S. aureus infection-induced phosphorylation of NF-κB p65, while overexpression enhanced this process, aligning with the mechanism observed by Mirza et al. in Shigella infection where NLRP10 potentiates NF-κB activity to promote inflammation20. NF-κB activation can promote the transcription of various pro-inflammatory cytokines (IL-6, TNF-α), forming an inflammatory amplification loop, which was also confirmed in our animal experiments. Second, NLRP10 itself may assemble or regulate a functional inflammasome complex. Our data show a positive correlation between NLRP10 expression levels and the activation of cleaved Caspase-1 and ASC, and the secretion of mature IL-1β/IL-18. Similarly, Gagandeep Kaur et al. found that in NLRP3-knockout mice or cells, secondhand smoke exposure significantly decrease in the levels of Caspase-1, IL-1β, and IL-1829. Notably, even when mitochondrial ROS were scavenged with MitoQ, NLRP10 overexpression still strongly drove Caspase-1 cleavage and IL-1β/IL-18 release, indicating that NLRP10 activation is not merely a passive consequence of ROS action but may possess an intrinsic ability to actively assemble the inflammasome. NLRP10 may act as a scaffold protein, directly recruiting ASC and Caspase-1 upon sensing mitochondrial damage signals, or indirectly functioning by modulating the activity of other inflammasomes such as NLRP3. One of the most striking findings of this study is the signaling autonomy of NLRP10. The observation that NLRP10 overexpression drives robust inflammatory responses even after mitochondrial ROS are scavenged by MitoQ reveals a “trigger-execution” model of NLRP10 activation: ROS-mediated mitochondrial damage serves as the triggering event that initiates NLRP10 activation, but once activated, the downstream signaling pathways acquire autonomous capacity, operating independently without requiring sustained ROS signals. This signaling autonomy has important biological implications: it enables cells to convert transient mitochondrial stress events into sustained and amplified inflammatory responses, ensuring that effective antimicrobial defense is maintained even after the initial oxidative stress has been resolved. Furthermore, this mechanism provides a theoretical basis for NLRP10’s role as a “molecular switch”, NLRP10 not only senses mitochondrial damage but also translates this sensing into autonomous execution signals that determine cell fate. We propose the following model: when ROS levels fall below a certain threshold, NLRP10 primarily exerts protective functions maintaining mitochondrial homeostasis; when ROS exceed the threshold to trigger NLRP10 activation, NLRP10 enters an autonomous execution mode, driving inflammasome assembly, a process that cannot be reversed even by subsequent ROS scavenging. This threshold-dependent autonomous activation mechanism ensures the appropriateness and controllability of inflammatory responses, preventing overreaction to transient stress. In SSTIs, an appropriate inflammatory response is crucial for pathogen clearance, but excessive inflammation and tissue damage are key factors driving disease progression30. This study elucidates that NLRP10 is a core regulatory molecule coordinating this balance. During early infection, NLRP10 may activate NF-κB and the inflammasome to initiate the expression of pro-inflammatory cytokines and antimicrobial peptides, aiding in infection defense, while its anti-apoptotic function helps maintain skin barrier integrity. However, in sustained or severe infections, profound mitochondrial damage leads to strong and persistent NLRP10 activation, driving excessive inflammatory cytokine release and potential pyroptosis, resulting in tissue necrosis and systemic inflammation, as evidenced in our animal model. Therefore, therapeutic strategies targeting NLRP10 should focus on precise modulation rather than simple inhibition or activation. For instance, enhancing NLRP10 function or stability in early infection or high-risk individuals may help strengthen host defense. In contrast, in severe infections with established excessive inflammation, moderating inhibition of NLRP10 activity may help control tissue damage while preserving its pro-survival functions. This study has several limitations. First, although the results suggest that NLRP10 may form an inflammasome, direct confirmation of the NLRP10-ASC-Caspase-1 complex in infected cells requires further validation through co-immunoprecipitation or proximity labeling assays. Second, the cleavage of GSDMD, the executor of pyroptosis, and the formation of membrane pores were not detected, and future studies are needed to confirm the mode of cell death. Furthermore, this study primarily focused on keratinocytes and did not explore the function of NLRP10 in infiltrating immune cells, which are crucial in the inflammatory network of SSTIs. Future research could employ cell-specific knockout mouse models to dissect the role of NLRP10 in different cell types. Finally, identifying small-molecule compounds that specifically modulate NLRP10 activity and evaluating their therapeutic potential in SSTI models are essential steps toward translating these findings into clinical applications. Furthermore, we did not assess the impact of altered NLRP10 expression on bacterial clearance in our in vivo or in vitro models. Therefore, we cannot entirely rule out the possibility that the observed inflammatory and tissue damage phenotypes are partially attributable to differences in bacterial burden. Future studies utilizing keratinocyte-specific NLRP10 knockout mouse models, combined with dynamic monitoring of bacterial load in vivo, are warranted to more precisely dissect the role of NLRP10 in balancing host defense against infection and immunopathological damage. In summary, this study reveals for the first time that ROS-mediated mitochondrial damage serves as a key upstream event activating NLRP10 during S. aureus skin infection. NLRP10 plays a central role in regulating cell death (apoptosis) and inflammatory intensity by integrating NF-κB signaling and inflammasome activation. This “double-edged sword” characteristic establishes NLRP10 as a critical molecular nexus connecting pathogen infection, mitochondrial stress, and host immunopathological outcomes. Context-dependent modulation of NLRP10 may offer novel therapeutic strategies for treating drug-resistant S. aureus-induced skin and soft tissue infections. Materials and methods Experimental animals The 9-week-old female C57BL/6 mice (18–22 g) used in this study were purchased from Shanghai SLAC Laboratory Animal Co., Ltd (License No. SCXK (Hu) 2022-0004) and kept in the SPF barrier facility of Hunter Biolnsight Technology, Inc (Facility License No. SYXK (Zhe) 2024-0003). The animal experiments involved in this study were approved by the Ethics Committee of Hangzhou Hunter Testing Biotechnology Co., Ltd. (Approval No. IACUC/HTYJ-11746-86), and all procedures complied with relevant animal welfare ethical guidelines. The reporting of this study adheres to the ARRIVE guidelines 2.0. Animal breeding environment maintains standard temperature and humidity and light and dark period, and provides unlimited drinking water and regular replacement of padding. Animal grouping and model preparation After a five-day acclimation period, twelve mice were randomly divided into two groups using a random number table: a control group (n = 6) and a model group (n = 6). All mice were shaved and depilated, followed by a 2-day moisturizing pretreatment prior to infection. Under isoflurane anesthesia, mice in the model group received a subcutaneous injection of 50 µL of methicillin-resistant MRSA suspension (4 × 107 CFU) into the shaved area31, with the control group receiving the same volume of sterile saline. The MRSA strain was provided by Professor Liu Qingzhong of Shanghai Hospital of Traditional Chinese Medicine. On day 4, all mice were euthanized by carbon dioxide inhalation. To quantitatively assess lesion progression, wound photographs with a fixed scale reference were taken daily for 4 consecutive days. ImageJ software was used to quantify the primary outcome measure, namely the lesion area. In addition, on day 4 post-infection, all mice were euthanized by carbon dioxide inhalation. Immediately after euthanasia, full-thickness skin tissues were collected from the same anatomical location at the edge of the lesion (within 2 mm from the ulcer margin) for each mouse. The collected tissues were processed differently according to the requirements of subsequent experiments: some tissues were fixed in 10% neutral-buffered formalin for histopathological analysis; some tissues were embedded in OCT compound and snap-frozen for TUNEL apoptosis detection. The remaining tissues were snap-frozen in liquid nitrogen and stored at −80 °C for Western blot, ELISA, and biochemical assays including ROS, LDH, NAD+/NADH ratio, and ATP measurements. Hematoxylin-eosin staining Full-thickness skin samples from the lesion site were collected post-euthanasia, fixed in 10% neutral-buffered formalin, and then processed through dehydration, clearing, and paraffin embedding. Tissue Sects. (4–5 μm) were stained with hematoxylin (Cat No. 61753 C, Shanghai Titan Scientific Co., Ltd.) and eosin (Cat No. 30086E, Shanghai Titan Scientific Co., Ltd.) for histopathological examination. Detection of ROS, LDH, NAD+/NADH ratio, and ATP levels in tissue samples Skin tissue homogenate supernatants stored at −80 °C were thawed on ice. The following parameters were measured according to the manufacturers’ instructions of the respective assay kits: total ROS levels in tissue homogenates were quantitatively detected using a ROS assay kit (Cat No. E004-1-1, NanJing JianCheng Bioengineering Institute) with a fluorescence microplate reader at excitation wavelength 500 nm and emission wavelength 525 nm; lactate dehydrogenase release was measured using an lactate dehydrogenase (LDH) assay kit (Cat No. C0016, Beyotime Biotechnology); the ratio of oxidized to reduced nicotinamide adenine dinucleotide (NADH/NAD+) was measured using a NAD_NADH assay kit (Cat No. S0175, Beyotime Biotechnology); adenosine triphosphate (ATP) content was measured using an ATP assay kit (Cat No. A095-2, NanJing JianCheng Bioengineering Institute). All assays were performed strictly following the manufacturers’ protocols, and results were normalized to protein concentration or tissue weight. TUNEL staining Following overnight fixation in 4% paraformaldehyde, tissues were paraffin-embedded and sliced into 20 μm sections. Post-deparaffinization and antigen retrieval (98 °C, pH 6.0), sections were incubated with 5% normal donkey serum for blocking. A green-fluorescence one-step TUNEL assay kit (Cat No. E-CK-A320, Elabscience) was then applied to detect apoptotic cells. Cell culture and modeling Human primary keratinocytes (Cat No. HUM-iCell-s002) were obtained from iCell Bioscience Inc., Shanghai. Cells were cultured in iCell Primary Keratinocyte Medium (Cat No. PriMed-iCell-010, iCell Bioscience Inc., Shanghai) under standard conditions: 37 °C, 5% CO2, 95% air atmosphere, and 70%−80% humidity. Human primary keratinocytes in logarithmic growth were seeded in 6-well plates and incubated with PBS as control. Subsequently, cells were infected with S. aureus at a multiplicity of infection of 30:1 for 3 h32. Cell transfection and grouping To investigate the function of NLRP10, both knockdown and overexpression experiments were performed. The siRNA targeting NLRP10 (si-NLRP10) and the NLRP10 overexpression plasmid (oe-NLRP10) were purchased from GenePharma (detailed information is provided in the Supplementary Materials). Transfections were carried out using Lipofectamine™ 3000 transfection reagent (Cat No. L3000-008, Invitrogen) strictly according to the manufacturer’s protocol. For knockdown experiments, cells were randomly assigned into the following groups: a blank control (Control), a negative control transfected with non-targeting siRNA (si-NC), and three experimental groups transfected with different NLRP10-specific siRNAs (si-NLRP10#1, si-NLRP10#2, and si-NLRP10#3). For overexpression experiments, cells were randomly assigned into: a blank control (Control), a negative control transfected with an empty vector (oe-NC), and an experimental group transfected with the NLRP10 overexpression plasmid (oe-NLRP10). 48 h post-transfection, the expression levels of NLRP10 were assessed at both mRNA and protein levels by quantitative real-time PCR (qPCR) and Western blot analysis, respectively, to confirm the transfection efficiency. Following successful establishment of NLRP10 knockdown and overexpression cell models, corresponding experimental groups were set up respectively. In the NLRP10 knockdown model, cells were randomly divided into six groups: Control (blank control), si-NC (negative control transfection), si-NLRP10 (NLRP10 knockdown), Model (S. aureus infection), Model + si-NC (infection + negative control transfection), and Model + si-NLRP10 (infection + NLRP10 knockdown). In the NLRP10 overexpression model, cells were randomly assigned to four groups: Model (infection control), Model+MitoQ (infection combined with mitochondrial-targeted antioxidant MitoQ treatment, Cat No. SML3152, Sigma), Model+MitoQ + oe-NC (infection combined with MitoQ and empty vector transfection), and Model+MitoQ + oe-NLRP10 (infection combined with MitoQ and NLRP10 overexpression transfection). For the overexpression groups, cells were pretreated with 50 nM MitoQ for 24 h after oe-NLRP10 transfection before subsequent experiments33. qPCR Total RNA was extracted from tissues using EZ-10 Spin Column Total RNA Isolation Kit (Cat No. B610583-0100, BBI). cDNA was synthesized with a reverse transcription kit (Cat No. PC7002, Aidlab Biotechnologies Co., Ltd.). mRNA levels of target genes were quantified by quantitative real-time PCR (Cat No. PC6202, Aidlab Biotechnologies Co., Ltd.), with GAPDH as the internal control. Relative expression was calculated using the 2−ΔΔCt method. The sequence information is shown in Table 1. Table 1Primer sequences.GeneForward PrimerReverse PrimerHuman NLRP10GATATGACCCTGTCTGAGGGCTGCTCCTCCTTAGGTCCATGAHuman GAPDHGAAGGTGAAGGTCGGAGTCGAAGATGGTGATGGGATTTC Primer sequences. Cell counting kit-8 assay Cells were seeded in 96-well plates and treated after 24 h of culture. Following the manufacturer’s protocol, CCK-8 reagent (Cat No. C0039, Beyotime Biotechnology) was added and incubated. Absorbance at 450 nm was measured after 1–4 h, and cell viability was calculated accordingly. Detection of mitochondrial ROS, LDH, ATP, and mitochondrial membrane potential in cell samples Mitochondrial ROS detection: Mitochondrial ROS levels were assessed using the MitoSOX™ Red mitochondrial superoxide indicator (Cat No. S0061S, Beyotime Biotechnology). Treated cells were incubated with 5 µM MitoSOX probe working solution in the dark at 37 °C for 10 min. After washing three times with PBS, images were captured using a fluorescence inverted microscope at 400× magnification. For each sample, five random fields were selected, and the mean fluorescence intensity was analyzed using ImageJ software to reflect mitochondrial ROS levels. And LDH levels were measured using an LDH assay kit (Cat No. C0016, Beyotime Biotechnology) according to the manufacturer’s protocol, with absorbance read at 490 nm. ATP levels were measured using an ATP assay kit (Cat No. A095-2, NanJing JianCheng Bioengineering Institute) according to the manufacturer’s instructions using a luminometer, and results were normalized to protein concentration. Mitochondrial membrane potential was assessed using the JC-1 fluorescent probe (Cat No. C2006, Beyotime Biotechnology). Treated cells were incubated with JC-1 working solution in the dark at 37 °C for 20 min. After washing with PBS, the ratio of red fluorescence (aggregates) to green fluorescence (monomers) was detected by flow cytometry to evaluate changes in mitochondrial membrane potential. Flow cytometry After collection, cells were washed twice with cold PBS. Cells were stained following the instructions of an Annexin V-FITC/PI apoptosis detection kit (Cat No. 556547, BD) under dark conditions. Apoptosis rates were analyzed by flow cytometry and quantified using FlowJo software. Detection of mitochondrial ROS levels Mitochondrial superoxide levels were assessed using a specific fluorescent probe kit (MitoSOX™ Red) (Cat No. S0061S, Beyotime Biotechnology). Treated cells were incubated with the probe working solution under dark conditions. Fluorescence intensity was measured with a fluorescence microscope to evaluate changes in mitochondrial ROS. Detection of mitochondrial membrane potential The fluorescent probe JC-1 was used to assess mitochondrial membrane potential. Following the designated treatments, cells were harvested and stained in the dark with JC-1 working solution (Cat No. C2006, Beyotime Biotechnology) as per the manufacturer’s protocol. Changes in the aggregates/monomer ratio were analyzed by flow cytometry to evaluate alterations in membrane potential. Enzyme linked immunosorbent assay (ELISA) Skin tissue homogenates were prepared from lesion-adjacent areas and used for cytokine quantification. All samples were aliquoted and stored at −80 °C until analysis.Levels of IL-1β, IL-18, interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) in tissue homogenates and cell culture supernatants were measured using specific ELISA kits (Cat No. IL-1β: RX203063M; IL-18: RX203064M; IL-6: RX203049M; TNF-α: RX202412M all from Quanzhou Ruixin Biotechnology Co., Ltd.) according to the manufacturers’ protocols. Western blot Following protein separation and membrane transfer, blots were blocked and incubated with primary antibodies overnight, then with HRP-conjugated secondary antibodies. After ECL development, protein bands were quantified using ImageJ software. Antibody information is provided in Table 2. Table 2Antibody information.ReagentFactoryCat No.Dilution ratioCleaved caspase-3 AntibodyAffinityAF70221 : 2000Bax AntibodyAffinityAF01201 : 3000NLRP10 AntibodyAbcamab1988101 : 2000Cleaved caspase-1 AntibodyAffinityAF40051 : 2000ASC AntibodyAffinityDF63041 : 2000NF-κB p65 AntibodyAffinityAF50061 : 2000p-NF-κB p65 AntibodyAffinityAF20061 : 2000Anti-rabbit IgG, HRP-linked AntibodyCST70741 : 6000GAPDH AntibodyProteintech10494-1-AP1 : 10,000 Antibody information. Statistical analysis Data are presented as the mean ± standard deviation (SD). Statistical analyses were performed using SPSS software (version 20.0). Prior to intergroup comparisons, the normality of data distribution (Shapiro-Wilk test) and homogeneity of variances (Levene’s test) were assessed. If the data met the assumptions of normality and homogeneity of variances, one-way analysis of variance (One-way ANOVA) was used for comparisons among multiple groups, and the independent samples Student’s t-test was used for comparisons between two groups. If the data violated the normality assumption, non-parametric tests were employed (Kruskal-Wallis test for multiple groups, Mann-Whitney U test for two groups). If the data were normally distributed but variances were heterogeneous, a corrected t-test (Welch’s t-test) or corresponding non-parametric tests were applied. P < 0.05 was considered statistically significant. Supplementary Information Below is the link to the electronic supplementary material. Supplementary Material 1 Supplementary Material 2 Author contributions Yan Chen : Conceptualization, Funding acquisition, Investigation, Project administration, Writing-original draft. Jieqiong Wei : Formal analysis, Investigation, Methodology, Writing-original draft. Shanshan Wang : Data curation, Investigation, Methodology, Visualization. Mengna Wang : Formal analysis, Funding acquisition, Validation. Xiaobo Ying : Data curation, Formal analysis, Validation. Chuanling Zhang : Conceptualization, Project administration, Supervision, Writing-review & editing. Funding This work was supported by [Hangzhou Agricultural and Social Development Sector Public Welfare Scientific Research Guidance Project] (Grant number [20241029Y122]), and [Xiaoshan District Science and Technology Plan Guidance Project] (Grant number [2025301]). Data availability The data that support the findings of this study are available from the corresponding author upon reasonable request. Declarations Competing interests The authors declare no competing interests. Ethical approval The animal experiments involved in this study were approved by the Ethics Committee of Hangzhou Hunter Testing Biotechnology Co., Ltd. (Approval No. IACUC/HTYJ-11746-86), and all procedures complied with relevant animal welfare ethical guidelines. The reporting of this study adheres to the ARRIVE guidelines 2.0. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. These authors contributed equally: Yan Chen, Jieqiong Wei and Shanshan Wang. References Associated Data Data Availability Statement The data that support the findings of this study are available from the corresponding author upon reasonable request.